Perspective Therapeutics

CATXNYSE United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$90.351 M

$0.79 -9.04%

Close of 6 Nov 2026

As of 6 Nov 2026, Perspective Therapeutics (CATX) has a market capitalization of $90.4M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$103.1M

Loss-making

Shares outstanding

114,151,663

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →

#295Unicycive TherapeuticsUNCY$96.7M
#296Neonc TechnologiesNTHI$95.0M
#297Perspective TherapeuticsCATX$90.4M
#298Polaryx TherapeuticsPLYX$89.7M
#299vTv TherapeuticsVTVT$86.4M

What if Perspective Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$247,362.79

Per share 312,524× higher

Bitcoin $1.53T

$13,384.37

Per share 16,910× higher

Apple $5.02T

$43,939.64

Per share 55,514× higher

Or at a round number

$200.0M $500.0M $1.00B $2.00B

Where these numbers come from

Share counts and financials for Perspective Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.